NCT06148493View on ClinicalTrials.gov

Real-World Usage of Asciminib Among Patients With Chronic Myeloid Leukemia in Chronic Phase in the United States Using a Large Claims Database

CompletedOBSERVATIONAL
Enrollment

425

Participants

Timeline

Start Date

September 20, 2022

Primary Completion Date

December 15, 2022

Study Completion Date

December 15, 2022

Conditions
Chronic Myeloid Leukemia
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY